141 related articles for article (PubMed ID: 16113501)
1. Further studies on the mechanism of rabies virus neutralization by a viral glycoprotein-specific monoclonal antibody, #1-46-12.
Irie T; Kawai A
Microbiol Immunol; 2005; 49(8):721-31. PubMed ID: 16113501
[TBL] [Abstract][Full Text] [Related]
2. Studies on the escape mutants of rabies virus which are resistant to neutralization by a highly conserved conformational epitope-specific monoclonal antibody #1-46-12.
Irie T; Matsuda Y; Honda Y; Morimoto K; Kawai A
Microbiol Immunol; 2002; 46(7):449-61. PubMed ID: 12222931
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
Raux H; Coulon P; Lafay F; Flamand A
Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
[TBL] [Abstract][Full Text] [Related]
4. Studies on the different conditions for rabies virus neutralization by monoclonal antibodies #1-46-12 and #7-1-9.
Irie T; Kawai A
J Gen Virol; 2002 Dec; 83(Pt 12):3045-3053. PubMed ID: 12466481
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of the rabies virus glycoproteins produced by virus-infected and G cDNA-transfected cells using a monoclonal antibody, #1-30-44, which recognizes an acid-sensitive epitope.
Kankanamge PJ; Irie T; Shoji J; Tochikura TS; Kawai A
Microbiol Immunol; 2003; 47(5):337-49. PubMed ID: 12825895
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of rabies virus neutralization.
Flamand A; Raux H; Gaudin Y; Ruigrok RW
Virology; 1993 May; 194(1):302-13. PubMed ID: 7683158
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the low pH-sensitive conformational epitope of rabies virus glycoprotein recognized by a monoclonal antibody #1-30-44.
Kankanamge PJ; Irie T; Mannen K; Tochikura TS; Kawai A
Microbiol Immunol; 2003; 47(7):507-19. PubMed ID: 12953844
[TBL] [Abstract][Full Text] [Related]
8. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719.
Ni Y; Tominaga Y; Honda Y; Morimoto K; Sakamoto S; Kawai A
Microbiol Immunol; 1995; 39(9):693-702. PubMed ID: 8577283
[TBL] [Abstract][Full Text] [Related]
9. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.
Fallahi F; Wandeler AI; Nadin-Davis SA
Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040
[TBL] [Abstract][Full Text] [Related]
10. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
[TBL] [Abstract][Full Text] [Related]
11. Further studies on the soluble form (gs) of rabies virus glycoprotein (g): molecular structure of gs protein and possible mechanism of the shedding.
Thirapanmethee K; Ootaki N; Sakai M; Lien CK; Kawai A
Microbiol Immunol; 2005; 49(8):733-43. PubMed ID: 16113502
[TBL] [Abstract][Full Text] [Related]
12. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody #3-9-16 recognizes one of the two isoforms of rabies virus matrix protein that exposes its N-terminus on the virion surface.
Ameyama S; Toriumi H; Takahashi T; Shimura Y; Nakahara T; Honda Y; Mifune K; Uchiyama T; Kawai A
Microbiol Immunol; 2003; 47(9):639-51. PubMed ID: 14584611
[TBL] [Abstract][Full Text] [Related]
14. Studies on the conditions required for structural and functional maturation of rabies virus glycoprotein (G) in G cDNA-transfected cells.
Sakai M; Kankanamge PJ; Shoji J; Kawata S; Tochikura TS; Kawai A
Microbiol Immunol; 2004; 48(11):853-64. PubMed ID: 15557743
[TBL] [Abstract][Full Text] [Related]
15. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment.
Papaneri AB; Wirblich C; Marissen WE; Schnell MJ
Vaccine; 2013 Dec; 31(49):5897-902. PubMed ID: 24120673
[TBL] [Abstract][Full Text] [Related]
16. Identification of binding epitope for anti-rabies virus glycoprotein single-chain Fv fragment FV57.
Gu TJ; Wei W; Duan Y; Jiang CL; Chen Y; Yu XH; Wu JX; Wu YG; Kong W
Protein Pept Lett; 2011 Nov; 18(11):1099-106. PubMed ID: 21675946
[TBL] [Abstract][Full Text] [Related]
17. Deficient Incorporation of Rabies Virus Glycoprotein into Virions Enhances Virus-Induced Immune Evasion and Viral Pathogenicity.
Li C; Zhang H; Ji L; Wang X; Wen Y; Li G; Fu ZF; Yang Y
Viruses; 2019 Mar; 11(3):. PubMed ID: 30836694
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acids controlling the low-pH-induced conformational change of rabies virus glycoprotein.
Gaudin Y; Raux H; Flamand A; Ruigrok RW
J Virol; 1996 Nov; 70(11):7371-8. PubMed ID: 8892855
[TBL] [Abstract][Full Text] [Related]
19. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
Turki I; Hammami A; Kharmachi H; Mousli M
Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
[TBL] [Abstract][Full Text] [Related]
20. Mapping of a type 1-specific and a type-common epitope on the E2 (gp53) protein of bovine viral diarrhea virus with neutralization escape mutants.
Deregt D; Bolin SR; van den Hurk J; Ridpath JF; Gilbert SA
Virus Res; 1998 Jan; 53(1):81-90. PubMed ID: 9617771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
